Terms: = Head and neck cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Clinical Outcome
3 results:
1. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
[TBL] [Abstract] [Full Text] [Related]
2. Staging nodal metastases in nasopharyngeal carcinoma: which method should be used to measure nodal dimension on MRI?
Ai QY; King AD; Mo FKF; Law BKH; Bhatia KS; Poon DMC; Kam MKM; Ma BB
Clin Radiol; 2018 Jul; 73(7):640-646. PubMed ID: 29636188
[TBL] [Abstract] [Full Text] [Related]
3. Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib.
Agulnik M; da Cunha Santos G; Hedley D; Nicklee T; Dos Reis PP; Ho J; Pond GR; Chen H; Chen S; Shyr Y; Winquist E; Soulieres D; Chen EX; Squire JA; Marrano P; Kamel-Reid S; Dancey J; Siu LL; Tsao MS
J Clin Oncol; 2007 Jun; 25(16):2184-90. PubMed ID: 17538163
[TBL] [Abstract] [Full Text] [Related]
